Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1997 Nov;92(3):346–353. doi: 10.1046/j.1365-2567.1997.d01-2341.x

Effect of B-cell receptor engagement on CD40-stimulated B cells.

B M Schilizzi 1, R Boonstra 1, T H The 1, L F de Leij 1
PMCID: PMC1363795  PMID: 9486107

Abstract

Activation of human B cells in vitro either by cross-linking of surface immunoglobulins (sIg) or by triggering CD40 antigen, in the presence of interleukin-10 (IL-10) and interleukin-2 (IL-2), may result in high levels of immunoglobulin secretion in vitro. We studied the combined effects of ligation of the B-cell receptor (BCR) and CD40 [with anti-CD40 monoclonal antibody (mAb)] on B-cell proliferation and production of human immunoglobulin. For this purpose highly purified splenic B cells were cultured with various combinations of anti-CD40 and IL-10/IL-2 or IL-4 in the presence of CD32-transfected L cells. Simultaneous cross-linking of the BCR was achieved by mAb held on CD32-L cells or Staphylococcus aureus (SA). We found that dual BCR and CD40 ligation with IL-10/IL-2 leads to reduced immunoglobulin G (IgG) secretion compared with B cells stimulated with either anti-CD40 and IL-10/IL-2, or compared with B cells stimulated with SA or anti-BCR mAb and IL-10/IL-2. Dual BCR and CD40 ligation with anti-immunoglobulin mAb (anti-kappa + anti-lambda light chains) but not with SA induced a similar reduction in IgM production. The reduced immunoglobulin secretion found during dual ligation is accompanied by increased proliferation. This was independent of cytokine stimulation but SA/CD40-induced proliferation was increased in the presence of IL-10/IL-2, although not with IL-4. The combination anti-kappa and anti-lambda with anti-CD40 showed a long-term suppression of IgG and IgM production (at least 14 days), while anti-kappa or anti-lambda alone, or SA, allowed a moderate recovery of immunoglobulin production by day 14. These results suggest that simultaneous B-cell antigen receptor cross-linking and CD40 engagement via CD40L on T cells induces strong initial proliferation. This may be followed later by antibody production depending on the strength of the BCR signal and the presence of the appropriate cytokines.

Full text

PDF
346

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arpin C., Déchanet J., Van Kooten C., Merville P., Grouard G., Brière F., Banchereau J., Liu Y. J. Generation of memory B cells and plasma cells in vitro. Science. 1995 May 5;268(5211):720–722. doi: 10.1126/science.7537388. [DOI] [PubMed] [Google Scholar]
  2. Clark E. A., Ledbetter J. A. Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50. Proc Natl Acad Sci U S A. 1986 Jun;83(12):4494–4498. doi: 10.1073/pnas.83.12.4494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Fluckiger A. C., Garrone P., Durand I., Galizzi J. P., Banchereau J. Interleukin 10 (IL-10) upregulates functional high affinity IL-2 receptors on normal and leukemic B lymphocytes. J Exp Med. 1993 Nov 1;178(5):1473–1481. doi: 10.1084/jem.178.5.1473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Gordon J., Cairns J. A., Millsum M. J., Gillis S., Guy G. R. Interleukin 4 and soluble CD23 as progression factors for human B lymphocytes: analysis of their interactions with agonists of the phosphoinositide "dual pathway" of signalling. Eur J Immunol. 1988 Oct;18(10):1561–1565. doi: 10.1002/eji.1830181014. [DOI] [PubMed] [Google Scholar]
  5. Gordon J., Millsum M. J., Flores-Romo L., Gillis S. Regulation of resting and cycling human B lymphocytes via surface IgM and the accessory molecules interleukin-4, CD23 and CD40. Immunology. 1989 Dec;68(4):526–531. [PMC free article] [PubMed] [Google Scholar]
  6. Itoh K., Hirohata S. The role of IL-10 in human B cell activation, proliferation, and differentiation. J Immunol. 1995 May 1;154(9):4341–4350. [PubMed] [Google Scholar]
  7. Itoh K., Inoue T., Ito K., Hirohata S. The interplay of interleukin-10 (IL-10) and interleukin-2 (IL-2) in humoral immune responses: IL-10 synergizes with IL-2 to enhance responses of human B lymphocytes in a mechanism which is different from upregulation of CD25 expression. Cell Immunol. 1994 Sep;157(2):478–488. doi: 10.1006/cimm.1994.1243. [DOI] [PubMed] [Google Scholar]
  8. Jelinek D. F., Lipsky P. E. Inhibitory influence of IL-4 on human B cell responsiveness. J Immunol. 1988 Jul 1;141(1):164–173. [PubMed] [Google Scholar]
  9. MacLennan I. C. Germinal centers. Annu Rev Immunol. 1994;12:117–139. doi: 10.1146/annurev.iy.12.040194.001001. [DOI] [PubMed] [Google Scholar]
  10. Paulie S., Rosén A., Ehlin-Henriksson B., Braesch-Andersen S., Jakobson E., Koho H., Perlmann P. The human B lymphocyte and carcinoma antigen, CDw40, is a phosphoprotein involved in growth signal transduction. J Immunol. 1989 Jan 15;142(2):590–595. [PubMed] [Google Scholar]
  11. Rousset F., Garcia E., Banchereau J. Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen. J Exp Med. 1991 Mar 1;173(3):705–710. doi: 10.1084/jem.173.3.705. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Rousset F., Garcia E., Defrance T., Péronne C., Vezzio N., Hsu D. H., Kastelein R., Moore K. W., Banchereau J. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1890–1893. doi: 10.1073/pnas.89.5.1890. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Rousset F., Peyrol S., Garcia E., Vezzio N., Andujar M., Grimaud J. A., Banchereau J. Long-term cultured CD40-activated B lymphocytes differentiate into plasma cells in response to IL-10 but not IL-4. Int Immunol. 1995 Aug;7(8):1243–1253. doi: 10.1093/intimm/7.8.1243. [DOI] [PubMed] [Google Scholar]
  14. Splawski J. B., Fu S. M., Lipsky P. E. Immunoregulatory role of CD40 in human B cell differentiation. J Immunol. 1993 Feb 15;150(4):1276–1285. [PubMed] [Google Scholar]
  15. Wheeler K., Pound J. D., Gordon J., Jefferis R. Engagement of CD40 lowers the threshold for activation of resting B cells via antigen receptor. Eur J Immunol. 1993 May;23(5):1165–1168. doi: 10.1002/eji.1830230528. [DOI] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES